BEND, OR, March 16, 2017 (GLOBE NEWSWIRE) -- Signal Bay, Inc. (OTC: SGBY) a Life Science company and the market leader in cannabis testing and laboratory services, is very pleased to announce that it has entered into a strategic advisory agreement with Senator Richard G. Polanco.  Senator Polanco is the former California State Senate Majority leader and member of the California State Assembly from 1990-2002.   Senator is best known for his work with the Latino Legislative Caucus which promotes legislation and policies that improve empowerment, public policy, diversity and social justice. 

“We are privileged to bring Senator Polanco on board to assist us in navigating the California landscape as Signal Bay continues the expansion of its EVIO Labs California division," stated William Waldrop, CEO of Signal Bay.  “Richard’s extensive working knowledge and relationships within local and state government, and recent work as a lobbyist will help Signal Bay maximize the value of our strategic investments in California this year and moving forward.”

Senator Polanco stated, "EVIO Labs has continued to raise the bar and set industry standards within the cannabis industry.  I feel they are poised for tremendous growth in the coming months and years ahead.  I'm excited to work with Signal Bay as they bring their management and technical experience to California that fuel the rapid growth of jobs as well as improve the public health and safety of California’s cannabis consumers.”

About Signal Bay, Inc.: Signal Bay, Inc. is an Oregon-based Life Sciences company. Through its three subsidiaries: EVIO Labs, Signal Bay Research and Signal Bay Services; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at or the company can be reached directly @ 1-888-544-EVIO.

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at or

Investor Relations: